open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:
Get Citation

60. Factors detremining local control in patients (Pts) with locally advanced breast cancer (Labc) managed with radiotherapy (RT) as the primary locoregional treatment

W. Roqowski, R. Dziadziuszko, J. Madrzak, M. Welnicka-Jaskiewicz, Peter Barrett-Lee, J. Jassem
DOI: 10.1016/S1507-1367(01)70430-0
·
Rep Pract Oncol Radiother 2001;6(1):55.

open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:

Abstract

Introduction

RT plays an important role in the management of LABC, yet clinical outcomes still remain far from satisfactory. The aim of this study was to evaluate retrospectively factors determining local control in a large series of consecutive LABC pts managed with RT as the primary locoregional treatment.

Material and methods

The records of 261 primarily inoperable LABC pts treated between 1991 and 1997 at two institutions: Medical University of Gdansk, Poland and Velindre NHS Trust, Cardiff, UK were analysed. All pts received megavoltage RT to the breast with two tangential fields, and the adjacent lymph node areas were irradiated using customised fields. Due to a large scale of RT doses and fractionation schedules, normalised total dose (NTD) was calculated for all patients using a linear quadratic model. In 241 pts RT constituted the only local treatment and the remaining 20 pts were subsequently subjected to mastectomy. Most pts received chemotherapy and/or endocrine therapy prior or after RT.

Results

Within the median follow-up of 37 months, locoregional recurrence occurred in 95 of 251 evaluable pts (38%). Three-year and five-year locoregional-free survival rates were 59% and 48%, respectively. At multivariate analysis of variables predicting the risk of locoregional relapse, inflammatory carcinoma (p<0.01; RR 2.1), T4 disease (p<0.01; RR 2.9) and involvement of supraclavicular lymph nodes (p<0.01; RR 2.4) were the most significant clinical factors, whereas response to RT (p<0.01; RR 1.2) and NTD (p<0.01; RR 0.7) were the most important therapeutic factors. Increasing the total dose to the tumour by 10 Gy was associated with 30% reduction of local relapse.

Conclusions

Due to large heterogeneity of LABC pts, judicious tailoring of RT, particularly in terms of dose prescribing, is essential to increase the chance of locoregional cure.

Abstract

Introduction

RT plays an important role in the management of LABC, yet clinical outcomes still remain far from satisfactory. The aim of this study was to evaluate retrospectively factors determining local control in a large series of consecutive LABC pts managed with RT as the primary locoregional treatment.

Material and methods

The records of 261 primarily inoperable LABC pts treated between 1991 and 1997 at two institutions: Medical University of Gdansk, Poland and Velindre NHS Trust, Cardiff, UK were analysed. All pts received megavoltage RT to the breast with two tangential fields, and the adjacent lymph node areas were irradiated using customised fields. Due to a large scale of RT doses and fractionation schedules, normalised total dose (NTD) was calculated for all patients using a linear quadratic model. In 241 pts RT constituted the only local treatment and the remaining 20 pts were subsequently subjected to mastectomy. Most pts received chemotherapy and/or endocrine therapy prior or after RT.

Results

Within the median follow-up of 37 months, locoregional recurrence occurred in 95 of 251 evaluable pts (38%). Three-year and five-year locoregional-free survival rates were 59% and 48%, respectively. At multivariate analysis of variables predicting the risk of locoregional relapse, inflammatory carcinoma (p<0.01; RR 2.1), T4 disease (p<0.01; RR 2.9) and involvement of supraclavicular lymph nodes (p<0.01; RR 2.4) were the most significant clinical factors, whereas response to RT (p<0.01; RR 1.2) and NTD (p<0.01; RR 0.7) were the most important therapeutic factors. Increasing the total dose to the tumour by 10 Gy was associated with 30% reduction of local relapse.

Conclusions

Due to large heterogeneity of LABC pts, judicious tailoring of RT, particularly in terms of dose prescribing, is essential to increase the chance of locoregional cure.

Get Citation
About this article
Title

60. Factors detremining local control in patients (Pts) with locally advanced breast cancer (Labc) managed with radiotherapy (RT) as the primary locoregional treatment

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 6, No 1 (2001)

Pages

55

Published online

2001-01-01

DOI

10.1016/S1507-1367(01)70430-0

Bibliographic record

Rep Pract Oncol Radiother 2001;6(1):55.

Authors

W. Roqowski
R. Dziadziuszko
J. Madrzak
M. Welnicka-Jaskiewicz
Peter Barrett-Lee
J. Jassem

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl